University of the Basque Country

About Products & Services Publications Contact Back to Exhibition

About us

Since 2001, our research group from the Pharmacy and Pharmaceutical Science’s Department has been recognized as a University of the Basque Country´s (UPV/EHU) “Consolidated group” by the Basque Government. The principal investigator is Dr José Luis Pedraz Muñoz. The members of the group has an extensive research, academic and management background. More precisely, the staff is composed by 2 professors, 9 senior lectures, 3 researchers hired by the CIBER BBN, and 10 graduate students.

It is remarkable our active implication in relevant research projects on the field of pharmaceutical technology, cellular therapy, characterization of biomaterials, and, especially, on the development of new sustained and controlled delivery systems for drugs, peptides, proteins, DNA and cells. During the last decade, these projects have been or are nowadays financed by national and international institutions. The University of the Basque Country supports some of them.

Likewise, since 1997, the Laboratory of Pharmacy and Pharmaceutical Technology is part of the Unit of Pharmaceutical Development (UPD), which is a section of TECNALIA, located at the Technological Park in Alava. TECNALIA Pharma Labs is a Contract Manufacturing and Development Organisation (CDMO) that offers high quality services under a solid quality system, with more than two decades at the service of the pharmaceutical.

We have set up the Joing Research Laboratory in Advanced Pharmaceutical Therapies with a 3D bioprinting unit that has been created with the objective of being certified in GMP.

We have participated in the following European projects:

  1. Title: Open Technology Platforms for medical devices Moore4medical
    Accelerating Innovation in Microfabricated Medical Devices: Optimization of lyophilization of biopharmaceutical products for their application in microfluidic devices. 866190 H2020 ECSEL 2019- 1.IA-two stage
    Funding Organization: ECSEL JTI 2019 H2020 European Commission
    Amount: € 578.750
    Years project duration: From June of 2020 To June of 2023.
  2. Title: 3D bioprinted personalised scaffolds for tissue regeneration of ankle joint.
    TRI-ankle 952981-2
    Funding organization: NMBP-21-2020: Biological scaffolds for tissue regeneration and repair Horizon 2020. European Commission
    Amount: € 531.435
    Years project duration: From June 2021 to July 2024
  3. Title: INNOVA4TB Improving TB management. This project has received funding from the European Union’s Horizon (2020) research and innovation programme under the Marie Sklodowska-Curie grant agreement No 823854.
    Funding Organization: European Commission
    Amount: € 45.000
    Years project duration: From September 2019 To July 2022
  4. Title: A pilot line for the next generation of smart catheters and implants. POSITION-II ECSEL Electronic Components and Systems for European Leadership 2017-2-783132.
    Funding Organization: Comisión Europea/Ministerio de Economía y Competitividad España
    Amount: 250.000 €
    Years Project Duration: From June 2018 To May 2021
  5. Title: DRIVE: Diabetes reversing implants with enhanced viability and long-term efficacy (645991-2)
    Funding Organization: COMUNIDAD EUROPEA H2020- NMP-10-2014: Biomaterials for the treatment of Diabetes Mellitus.
    Amount: 550.000 euros (Total amount €8, 832,061.50. )
    Years Project Duration: From 2015 To 2018